부산대학교 도서관

Pearson AD; ACCELERATE, Europe, Belgium. Electronic address: andy1pearson@btinternet.com.; DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Macy ME; Childrens' Hospital, CO, USA.; de Rojas T; ACCELERATE, Europe, Belgium.; Donoghue M; US Food and Drug Administration, Silver Springs, MD, USA.; Weiner S; Children's Cancer Cause, Washington, DC, USA.; Knoderer H; Loxo Oncology at Lilly, USA.; Bernardi R; Genentech, A Member of the Roche Group, South San Francisco, CA USA.; Buenger V; Coalition Against Childhood Cancer (CAC2), Philadelphia, USA.; Canaud G; Necker Enfants Malades Hospital, Paris, France.; Cantley L; Harvard Medical School, Boston, USA.; Chung J; Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.; Fox E; St Jude Children's Research Hospital, TN, USA.; Friend J; Kazia Therapeutics, NJ, USA.; Glade-Bender J; Memorial Sloan Kettering Cancer Centre, New York, USA.; Gorbatchevsky I; Celcuity Inc., Minneapolis, MN, USA.; Gore L; Childrens' Hospital, CO, USA.; Gupta A; The Hospital for Sick Children (SickKids), Princess Margaret Hospital Toronto, Canada.; Hawkins DS; Seattle Children's Hospital, Seattle, USA.; Juric D; Massachusetts General Hospital, Boston, USA.; Lang LA; Rally Foundation for Childhood Cancer Research, Atlanta, GA, USA.; Leach D; National Brain Tumor Society, Newton, MA, USA.; Liaw D; Merck Sharp & Dohme, NJ, USA.; Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands.; Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands.; Lindberg G; The EVAN Foundation, Germantown, MD, USA.; Lindberg W; The EVAN Foundation, Germantown, MD, USA.; Ludwinski D; Solving Kids' Cancer, New York, USA.; Marshall L; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.; Mazar A; Actuate Therapeutics Inc., For worth, TX, USA.; McDonough J; The Andrew McDonough B+ Foundation, Wilmington, DE, USA.; Nysom K; Righospitalet, Copenhagen, Denmark.; Ours C; National Human Genome Research Institute/National Institutes of Health, MD, USA.; Pappo A; St Jude Children's Research Hospital, TN, USA.; Parsons DW; Texas Children's Cancer and Hematology Center, TX, USA.; Rosenfeld A; AstraZeneca, Waltham, MA, USA.; Scobie N; Zoe4Life, Sullens, Switzerland.; Smith M; National Cancer Institute, MD, USA.; Taylor D; PORT (Paediatric Oncology Reference Team), London, UK.; Weigel B; University of Minnesota, Minneapolis, USA.; Weinstein A; Pediatric Brain Tumor Foundation of the US, Atlanta, USA.; Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands.; Vassal G; ACCELERATE, Europe, Belgium; Gustave Roussy Cancer Centre, Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pearson AD; ACCELERATE, Brussels, Belgium.; Vassal G; ACCELERATE, Brussels, Belgium.; Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.; Scobie N; Zoe4Life, Sullens, Switzerland.; Bird N; Solving Kids' Cancer UK, London, United Kingdom.; Blanc P; Imagine for Margo, Saint-Germain-en-Laye, France.; Vormoor HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.; Calkoen FG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Locatelli F; Department of Pediatric Haematology/Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.; Del Bufalo F; Department of Pediatric Haematology/Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.; AND Catholic University of the Sacred Heart, Rome, Italy.; Rives S; CAR T-cell Unit, Leukemia and Lymphoma Department, Pediatric Cancer Center Barcelona /Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Jacoby E; The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Balduzzi A; Pediatrics, Hematopoietic Stem Cell Transplantation Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Bourquin JP; Department of Pediatric Hematology and Oncology, Immunology and Stem Cell Transplantation, University Children's Hospital, Zurich, Switzerland.; Baruchel A; Department of Pediatric Hemato-Immunology, Hôpital Universitaire Robert Debré (APHP and Université Paris Cité), Paris, France.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Pearson AD; ACCELERATE, Europe. Electronic address: andy1pearson@btinternert.com.; Allen C; Texas Children Hospital, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA.; Fangusaro J; Children's Healthcare of Atlanta, USA; Emory University School of Medicine, Atlanta, USA.; Hutter C; St. Anna Children's Hospital, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria.; Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Heidelberg University Hospital, Heidelberg, Germany; German Cancer Research Center, Heidelberg, Germany.; Weiner S; Children's Cancer Cause, Washington DC, USA.; Reaman G; US Food and Drug Administration, Silver Springs, USA.; Russo M; Novartis, New Jersey, USA.; Bandopadhayay P; Department of Pediatrics, Harvard Medical School, Broad Institute, USA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, USA.; Ahsan S; Merck & Co., Inc, Rahway, NJ, USA.; Barone A; US Food and Drug Administration, Silver Springs, USA.; Barry E; Day One Biopharmaceuticals, San Francisco, USA.; de Rojas T; ACCELERATE, Europe.; Fisher M; The Children's Hospital of Philadelphia, Philadelphia, USA.; Fox E; St Jude Children's Research Hospital, Tennessee, USA.; Bender JG; Memorial Sloan Kettering Cancer Centre, New York, USA.; Gore L; Children's Hospital Colorado, USA; University of Colorado, USA.; Hargrave D; UCL Great Ormond Street Institute of Child Health, London UK.; Hawkins D; Seattle Children's Hospital, USA; Children's Oncology Group, Seattle, USA.; Kreider B; BioMed Valley Discoveries, Kansas City, MO, USA.; Langseth AJ; SpringWorks Therapeutics, Stamford, CT, USA.; Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Marotti M; Boehringer Ingelheim, Germany.; Marshall LV; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.; Nasri K; Pierre-Fabre, Paris, France.; Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency, (EMA), Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium.; Nysom K; Righospitalet, Copenhagen, Denmark.; Pappo A; St Jude Children's Research Hospital, Tennessee, USA.; Rossato G; F. Hoffmann-La Roche AG, Basel, Switzerland.; Scobie N; Zoe4Life, Sullens, Switzerland.; Smith M; National Cancer Institute, Maryland, USA.; Stieglitz E; UCSF Benioff Children's Hospital San Francisco, USA.; Weigel B; University of Minnesota, Minneapolis, USA.; Weinstein A; Pediatric Brain Tumor Foundation, Atlanta, USA.; Viana R; Alexion Pharmaceuticals, Zurich, Switzerland.; Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Vassal G; ACCELERATE, Europe; Gustave Roussy Cancer Centre, Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Martínez-Peña F; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Pearson AD; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Tang EL; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Kuburich NA; Department of Translational Molecular Pathology, The University of Texas, MD, Anderson, USA.; Mani SA; Department of Translational Molecular Pathology, The University of Texas, MD, Anderson, USA.; Schultz PG; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Bollong MJ; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA. Electronic address: mbollong@scripps.edu.; Lairson LL; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037, USA. Electronic address: llairson@scripps.edu.

Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

Park JR; Seattle Children's Hospital, Seattle, Washington, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.; Villablanca JG; Children's Hospital Los Angeles, Los Angeles, California, USA.; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; Hero B; Children's Hospital, University of Cologne, Cologne, Germany.; Kushner BH; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Wheatley K; University of Birmingham, Birmingham, UK.; Beiske KH; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Ladenstein RL; Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.; Baruchel S; Hospital for Sick Children, Toronto, Ontario, Canada.; Macy ME; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.; Moreno L; Division of Paediatric Haematology and Oncology, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Seibel NL; Clinical Investigations Branch, National Cancer Institute, Bethesda, Maryland, USA.; Pearson AD; Division of Cancer Therapeutics, Institute of Cancer Research, Sutton, UK.; Division of Clinical Studies, Institute of Cancer Research, Sutton, UK.; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, Sutton, UK.; Matthay KK; Department of Pediatrics, School of Medicine, University of California San Francisco, San Francisco, California, USA.; Valteau-Couanet D; Department of Pediatric Oncology, Gustave Roussy, Villejuif, France.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Pearson AD; ACCELERATE, Europe. Electronic address: andy1pearson@btinternet.com.; Gaspar N; Gustave Roussy Cancer Centre, Paris, France.; Janeway K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Campbell-Hewson Q; Great North Children's Hospital, Newcastle, UK.; Lawlor ER; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.; Copland C; ACCELERATE, Europe; Euro Ewings Consortium, Europe, UK.; Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency (EMA), Netherlands; Federal Agency for Medicines and Health Products, Belgium.; Benzaghou F; Ipsen Pharma, Cambridge, MA, USA.; Weiner S; Children's Cancer Cause, USA.; Weigel B; University of Minnesota, Minneapolis, USA.; Weiss AR; Maine Medical Center, Portland, ME, USA.; Strauss SJ; University College London, London, UK.; Smith M; National Cancer Institute, USA.; Setty BA; Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH, USA.; Seibel N; National Cancer Institute, USA.; Scobie N; Zoe4Life, Switzerland.; Pappo A; St Jude Children's Research Hospital, USA.; Okpara CE; Eisai GmbH, Frankfurt, Germany.; Nysom K; Righospitalet, Denmark.; McDonough J; The Andrew McDonough B+ Foundation, USA.; Marshall LV; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.; Ludwinski D; Solving Kids' Cancer, USA.; Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Netherlands.; Knudsen S; Allarity Therapeutics, MA, USA.; Kauh J; HUTCHMED International Corporation, USA.; Hsieh A; Blueprint Medicines, Boston, MA, USA.; Heenen D; KickCancer, Belgium.; Hawkins DS; Seattle Children's Hospital, USA; Children's Oncology Group, USA.; Graham A; MIB Agents, Osteosarcoma Alliance, USA.; Garmey E; Oncoheroes Biosciences, Boston, MA, USA.; DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Fox E; St Jude Children's Research Hospital, USA.; Donoghue M; US Food and Drug Administration, USA.; de Rojas T; ACCELERATE, Europe.; Chung J; Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.; Casanova M; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Brennan B; Royal Manchester Children's Hospital, Manchester, UK.; Bishop M; St Jude Children's Research Hospital, USA.; Buenger V; Coalition Against Childhood Cancer (CAC2), USA.; Reaman G; US Food and Drug Administration, USA.; Vassal G; ACCELERATE, Europe; Gustave Roussy Cancer Centre, Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Moore AS; Faisal A; Gonzalez de Castro D; Bavetsias V; Sun C; Atrash B; Valenti M; de Haven Brandon A; Avery S; Mair D; Mirabella F; Swansbury J; Pearson AD; Workman P; Blagg J; Raynaud FI; Eccles SA; Linardopoulos S; Moore, A S; Faisal, A

Leukemia (08876924). Jul2012, Vol. 26 Issue 7, p1462-1470. 9p.

De Bernardi B; Gerrard M; Boni L; Rubie H; Cañete A; Di Cataldo A; Castel V; Forjaz de Lacerda A; Ladenstein R; Ruud E; Brichard B; Couturier J; Ellershaw C; Munzer C; Bruzzi P; Michon J; Pearson AD

Journal of Clinical Oncology; 3/1/2009, Vol. 27 Issue 7, p1034-1040, 7p

Bagatell R; Beck-Popovic M; London WB; Zhang Y; Pearson AD; Matthay KK; Monclair T; Ambros PF; Cohn SL; Bagatell, Rochelle; Beck-Popovic, Maja; London, Wendy B; Zhang, Yang; Pearson, Andrew D J; Matthay, Katherine K; Monclair, Tom; Ambros, Peter F; Cohn, Susan L; International Neuroblastoma Risk Group

Journal of Clinical Oncology; 1/20/2009, Vol. 27 Issue 3, p365-370, 6p

Cohn SL; Pearson AD; London WB; Monclair T; Ambros PF; Brodeur GM; Faldum A; Hero B; Iehara T; Machin D; Mosseri V; Simon T; Garaventa A; Castel V; Matthay KK; INRG Task Force; Cohn, Susan L; Pearson, Andrew D J; London, Wendy B; Monclair, Tom

Journal of Clinical Oncology; 1/10/2009, Vol. 27 Issue 2, p289-297, 9p